Molecular Imaging in Gastric Cancer: [¹⁸F]FDG and Fibroblast Activation Protein-Targeted PET/CT [0.03%]
胃癌的分子影像：[¹⁸F]FDG和成纤维活化蛋白靶向PET/CT
Chaninart Sakulpisuti,Minseok Suh
Chaninart Sakulpisuti
Gastric cancer remains a major global health burden, and accurate staging and response assessment are essential for optimal management. 2-[¹⁸F]-Fluoro-2-deoxy-D-glucose ([¹⁸F]FDG) positron emission tomography (PET)/computed tomography (...
Isabella Michelon,Anwaar Saeed
Isabella Michelon
Young-onset gastric cancer (YOGC) is an increasingly recognized subtype that challenges traditional assumptions about gastric cancer (GC) biology. Although the overall global incidence of GC continues to decline, the rising burden among ind...
Conor Vaessen,Kieran Redpath,Emily Schulpen et al.
Conor Vaessen et al.
Hereditary diffuse gastric cancer (HDGC) is a dominantly inherited cancer syndrome characterized by the early onset of diffuse gastric cancer (DGC) and lobular breast cancer. HDGC is predominantly caused by germline truncating mutations in ...
Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy [0.03%]
胃癌分子亚型的演变：从过去的分类到现在的共识及未来精准治疗的方向
Ju-Seog Lee
Ju-Seog Lee
Gastric cancer is a biologically heterogeneous disease. The advent of high-throughput multi-omic technologies has revolutionized our understanding of gastric cancer by deconstructing this heterogeneous entity into distinct and more homogene...
Epidemiology of Gastric Cancer in Korea (1999-2022): Incidence, Survival, and 5-Year Conditional Relative Survival [0.03%]
韩国胃癌流行病学（1999-2022）：发病率、生存率和五年相对累积生存率
Ki Bum Park,Mee Joo Kang,Johyun Ha et al.
Ki Bum Park et al.
Purpose: This study evaluated long-term trends in gastric cancer epidemiology and survival with a focus on conditional relative survival (CRS). Materials ...
Journal of Gastric Cancer's Ascent and the Enduring Contributions of Dr. Keun Won Ryu [0.03%]
gastric cancer的崛起及Ryu Keun Won博士的贡献永存
Han Hong Lee
Han Hong Lee
Rethinking Neoadjuvant Therapy: A Critical Evaluation of Exclusion Criteria in Gastric Cancer Surgery Studies [0.03%]
重新思考新辅助治疗：胃癌手术研究中排除标准的批判性评估
Yusuf Ilhan,Halil Goksel Guzel,Onur Yazdan Balcik
Yusuf Ilhan
Correlation and Overlap Between Claudin 18.2 and FGFR2b Overexpression: A Tissue Microarray Study With 1,538 Gastric Carcinomas [0.03%]
Claudin 18.2与FGFR2b高表达的关联及重叠：1538例胃癌样本的组织芯片研究
Soomin Ahn,Inwoo Hwang,Kyoung-Mee Kim
Soomin Ahn
Purpose: Claudin 18.2 (CLDN18.2) and fibroblast growth factor receptor 2b (FGFR2b) have recently emerged as promising therapeutic targets for advanced gastric cancer (GC). Before integrating CLDN18.2 and FGFR2b into routi...
Clinical Outcomes According to Surgical Strategies in Proximal Early Gastric Cancer: A Systematic Review and Network Meta-Analysis [0.03%]
早期胃癌近端部位不同手术方式的临床疗效系统评价和网络 meta 分析
Hyun-Jae Lee,Jane Chungyoon Kim,Sa-Hong Kim et al.
Hyun-Jae Lee et al.
Purpose: Many surgical methods have been developed for the optimal treatment of proximal early gastric cancer (GC); however, these approaches are still controversial. Proximal gastrectomy with direct esophagogastrostomy (...
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis [0.03%]
伴有腹膜转移的胃癌具有独特的免疫抑制性肿瘤微环境
Hongsik Kim,Minsuk Kwon,Sun Kyung Lee et al.
Hongsik Kim et al.
Purpose: Immunotherapy combined with chemotherapy is the standard palliative treatment for gastric cancer. However, peritoneal metastases are often resistant to immunotherapy, underscoring the need to better understand th...